Cite

HARVARD Citation

    Meniawy, T. et al. (2016). PD-L1 on peripheral blood T lymphocytes is prognostic in patients with non-small cell lung cancer (NSCLC) treated with EGFR inhibitors. Lung cancer. pp. 9-16. [Online]. 
  
Back to record